EBITDA Turns Negative for Hemagen Diagnostics' Twelve Months
Stock Quote:(N/A:HMGN)
09/01/2009
0.00
N/A
N/A
EBITDA Turns Negative for Hemagen Diagnostics' Twelve Months
Last
Price Change
% Chg
Volume
New York, NY, September 1, 2009-EbitdaEXTRA reports that EBITDA for Hemagen Diagnostics, Inc. (OTC:HMGN) for its twelve months ended June 30, 2009 was a negative $(149,647), compared with a positive E ... read full story
U.S. markets rallied today following the release of a positive January employment report. The Nasdaq Composite hit at an 11-year high and the Dow closed at its highest level in 3 1/2 years after the report showed that the U.S. economy added 243,000 n ... read full story
N/A 
